News
AngioDynamics delivered strong Q3 results, highlighting growth across its MedTech portfolio. With raised guidance and increasing adoption in key areas like Mechanical Thrombectomy and NanoKnife, the ...
Hosted on MSN10d
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 68.28%: Read This Before Placing a BetAngioDynamics (ANGO) closed the last trading session at $9.11, gaining 0.1% over the past four weeks, but there could be ...
Zacks.com on MSN6d
Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year?Here is how AngioDynamics (ANGO) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.
A total of 1 analyst ratings have been received for AngioDynamics, with the consensus rating being Buy. The average one-year ...
AngioDynamics, Inc.’s ANGO share price has surged by 12.42%, which has investors questioning if this is right time to sell.
Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have ...
AngioDynamics Inc. (NASDAQ : ANGO) on Wednesday reported a third-quarter 2025 adjusted EPS of 3 cents, compared to the consensus for a per-share loss of 13 cents. The maker of medical Instruments and ...
AngioDynamics, Inc. ANGO reported an adjusted earnings per share (EPS) of 3 cents for third-quarter fiscal 2025, narrower than the year-ago quarter’s adjusted loss per share of 16 cents and ...
LATHAM, N.Y. (AP) — LATHAM, N.Y. (AP) — AngioDynamics Inc. (ANGO) on Wednesday reported a loss of $4.4 million in its fiscal third quarter. On a per-share basis, the Latham, New York-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results